Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1325218

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1325218

Neuromodulation

PUBLISHED:
PAGES: 298 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 14850

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Neuromodulation Market to Reach $11.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Neuromodulation estimated at US$5.9 Billion in the year 2022, is projected to reach a revised size of US$11.6 Billion by 2030, growing at a CAGR of 8.9% over the analysis period 2022-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is projected to record a 8.9% CAGR and reach US$5.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Deep Brain Stimulation segment is readjusted to a revised 9.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 10.6% CAGR

The Neuromodulation market in the U.S. is estimated at US$2.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$898.5 Million by the year 2030 trailing a CAGR of 10.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 9.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Select Competitors (Total 83 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Aleva Neurotherapeutics SA
  • Bioness Inc.
  • Beijing Pins Medical Co., Ltd.
  • Axonics Modulation Technologies, Inc.
  • Biegler GmbH
  • Cirtec Medical Corporation
  • Cala Health
  • BioControl Medical Ltd.
  • Atlantic Therapeutics Group Limited
  • Bio-Medical Research Limited
  • Capitol Pain Institute
  • Autonomix Medical
  • Bioinduction
Show more
Product Code: MCP13576

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Neuromodulation - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Neurological Disorders
    • A Prelude to Neuromodulation
    • Indications for Neuromodulation Therapy
    • Impact of Covid-19 and a Looming Global Recession
    • 2020 Marked as a Year of Disruption & Transformation
    • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Global Neuromodulation Market Buckles under COVID-19 Strain
    • Effects of COVID-19 on the Nervous System Sheds Focus on Neuromodulation Applications
  • GLOBAL MARKET OVERVIEW
    • Neuromodulation Market Set for a Robust Growth
    • Neuromodulation Market by Segment
    • Spinal Cord Stimulation (SCS) and Deep Brain Stimulation (DBS) Represents the Largest Segments
    • Neuromodulation Devices by Technology
    • Spinal Cord Stimulation Market (2020): Dollar Market Share of Leading Players in Percentage
    • Neuromodulation Market by Application
    • Growing Clinical Applications to Drive Demand
    • US and Europe Dominate the Market
    • Asia-Pacific and other Emerging Regions Display Impressive Growth Potential
    • Competition
    • Select FDA Approved Neuromodulation Devices in Recent Years
    • Recent Market Activity
    • Market Restraints and Challenges
  • WORLD BRANDS
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • High Incidence of Neurological Disorders: A Key Market Driver
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
    • Global Alzheimer's Prevalence by Age Group
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Global DBS Market by Leading Player (2020E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott
    • Select Available Deep Brain Stimulation Devices Available in the Market
    • Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
    • Epilepsy Incidence by Type (2019): Percentage Share Breakdown for Idiopathic and Symptomatic Epilepsy
    • Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy
    • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
    • Recent Developments in Spinal Cord Injury Treatment
    • TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
    • Non-Invasiveness of TMS (Transcranial Magnetic Stimulation) Propelling the adoption of TMS devices
    • Neuromodulation Technologies to Gain Preference Over Opioids
    • Tibial Neuromodulation to Impact Overactive Bladder Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Spinal Cord Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Sacral Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Transcutaneous Electrical Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Transcutaneous Electrical Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Transcutaneous Electrical Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Repetitive Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Repetitive Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Repetitive Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Failed Back Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Parkinson`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Parkinson`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Parkinson`s Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 39: World 16-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 42: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 43: World Neuromodulation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: World 16-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: China 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • FRANCE
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: France 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: France 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: UK 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Rest of World Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Rest of World 16-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 119: Rest of World Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Rest of World Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Rest of World 16-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!